The Food and Drug Administration outlined its response to monkeypox in the United States, including its efforts in the areas of diagnostics, vaccines and therapeutics, in a bulletin issued on Friday, July 29, 2022.
The agency also recently launched a dedicated website that details the agency’s monkeypox preparedness and response and contains news items related to the agency’s role in addressing the outbreak.
AABB also released a new toolkit, “Monkeypox Resources to Consider,” that includes member-exclusive resources. The toolkit contains the monkeypox virus fact sheet and member-exclusive outbreak summary, both updated last week by AABB’s Transfusion Transmitted Diseases (TTD) Committee. The toolkit also includes eligibility information for donors who have received a smallpox vaccine with a corresponding flow chart and information for blood centers considering the development of a local deferral.AABB release